A pill combining low doses of three blood pressure-lowering medications - telmisartan (20 mg), amlodipine (2.5 mg) and chlorthalidone (12.5 mg) - significantly increased the number of patients reaching blood pressure targets compared with usual care, according to findings of a study reported March 12, 2018 at the American College of Cardiologys 67th Annual Scientific Session in Orlando, Florida.